Altimmune, Inc. (ALT) bonds
ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$1.56−0.08 (-5.17%)
Close on Nov 16, 2026Market cap $303.45MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$34.74M
Long-term debt
Net debt
-$28.27M
After $63.01M of cash
Implied interest rate
–
FY2025 interest ÷ average debt
Interest coverage
-57.8×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Altimmune's 10-Q for the period ended Nov 5, 2025
| Issue | Coupon | Amount issued |
|---|---|---|
| First term loan tranche | – | $15.00M |
| Fourth term loan tranche | – | $80.00M |
| Second term loan tranche | – | $20.00M |
| Term loan | 9.70% | $125.00M |
| Third term loan tranche | – | $10.00M |
Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.
See a number that looks wrong?